nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA9—breast cancer	0.17	0.463	CbGaD
Celecoxib—CYP2D6—breast cancer	0.0571	0.156	CbGaD
Celecoxib—CYP3A4—breast cancer	0.0489	0.134	CbGaD
Celecoxib—PTGS2—breast cancer	0.0479	0.131	CbGaD
Celecoxib—ALB—breast cancer	0.0427	0.117	CbGaD
Celecoxib—ABCC4—Fluorouracil—breast cancer	0.0243	0.0909	CbGbCtD
Celecoxib—CYP2C9—Anastrozole—breast cancer	0.0197	0.0738	CbGbCtD
Celecoxib—CYP3A4—Exemestane—breast cancer	0.0151	0.0566	CbGbCtD
Celecoxib—CYP2C9—Idarubicin—breast cancer	0.0149	0.0559	CbGbCtD
Celecoxib—CYP2D6—Idarubicin—breast cancer	0.0136	0.0511	CbGbCtD
Celecoxib—ABCC4—Methotrexate—breast cancer	0.0134	0.0501	CbGbCtD
Celecoxib—CYP3A4—Letrozole—breast cancer	0.0128	0.0481	CbGbCtD
Celecoxib—CYP3A4—Anastrozole—breast cancer	0.0114	0.0429	CbGbCtD
Celecoxib—CYP3A4—Toremifene—breast cancer	0.0105	0.0392	CbGbCtD
Celecoxib—CYP3A4—Fulvestrant—breast cancer	0.00974	0.0365	CbGbCtD
Celecoxib—ALB—Irinotecan—breast cancer	0.00937	0.0351	CbGbCtD
Celecoxib—ALB—Fluorouracil—breast cancer	0.00899	0.0337	CbGbCtD
Celecoxib—CYP3A4—Thiotepa—breast cancer	0.00868	0.0325	CbGbCtD
Celecoxib—CYP2C9—Capecitabine—breast cancer	0.00818	0.0306	CbGbCtD
Celecoxib—CYP3A4—Ixabepilone—breast cancer	0.00794	0.0297	CbGbCtD
Celecoxib—CYP3A4—Lapatinib—breast cancer	0.00764	0.0286	CbGbCtD
Celecoxib—CYP2D6—Vinorelbine—breast cancer	0.00666	0.025	CbGbCtD
Celecoxib—CYP2C9—Tamoxifen—breast cancer	0.00658	0.0246	CbGbCtD
Celecoxib—CYP2D6—Tamoxifen—breast cancer	0.00602	0.0225	CbGbCtD
Celecoxib—CYP3A4—Raloxifene—breast cancer	0.00579	0.0217	CbGbCtD
Celecoxib—CYP2C9—Paclitaxel—breast cancer	0.00512	0.0192	CbGbCtD
Celecoxib—ALB—Methotrexate—breast cancer	0.00496	0.0186	CbGbCtD
Celecoxib—CYP2C9—Fluorouracil—breast cancer	0.00485	0.0182	CbGbCtD
Celecoxib—CYP3A4—Vinorelbine—breast cancer	0.00424	0.0159	CbGbCtD
Celecoxib—CYP2D6—Vinblastine—breast cancer	0.00411	0.0154	CbGbCtD
Celecoxib—CYP3A4—Tamoxifen—breast cancer	0.00383	0.0143	CbGbCtD
Celecoxib—CYP3A4—Mitoxantrone—breast cancer	0.00373	0.014	CbGbCtD
Celecoxib—CYP3A4—Paclitaxel—breast cancer	0.00298	0.0112	CbGbCtD
Celecoxib—CYP3A4—Irinotecan—breast cancer	0.00294	0.011	CbGbCtD
Celecoxib—PDPK1—mammary gland—breast cancer	0.00282	0.0598	CbGeAlD
Celecoxib—CYP3A4—Vinblastine—breast cancer	0.00261	0.00978	CbGbCtD
Celecoxib—CYP2D6—Doxorubicin—breast cancer	0.00252	0.00945	CbGbCtD
Celecoxib—PDPK1—nipple—breast cancer	0.00234	0.0494	CbGeAlD
Celecoxib—CYP3A4—Docetaxel—breast cancer	0.00215	0.00806	CbGbCtD
Celecoxib—PDPK1—embryo—breast cancer	0.00193	0.0408	CbGeAlD
Celecoxib—CYP3A4—Doxorubicin—breast cancer	0.0016	0.00601	CbGbCtD
Celecoxib—PDPK1—uterus—breast cancer	0.0013	0.0275	CbGeAlD
Celecoxib—PDPK1—pituitary gland—breast cancer	0.00128	0.027	CbGeAlD
Celecoxib—PDPK1—adipose tissue—breast cancer	0.00127	0.0269	CbGeAlD
Celecoxib—PDPK1—female reproductive system—breast cancer	0.00117	0.0247	CbGeAlD
Celecoxib—PDPK1—adrenal gland—breast cancer	0.00114	0.0241	CbGeAlD
Celecoxib—CA5A—female reproductive system—breast cancer	0.0011	0.0232	CbGeAlD
Celecoxib—PDPK1—female gonad—breast cancer	0.00106	0.0225	CbGeAlD
Celecoxib—MAPK14—embryo—breast cancer	0.00103	0.0218	CbGeAlD
Celecoxib—CA5B—mammary gland—breast cancer	0.00103	0.0218	CbGeAlD
Celecoxib—PDPK1—endocrine gland—breast cancer	0.000989	0.0209	CbGeAlD
Celecoxib—CA5A—endocrine gland—breast cancer	0.000928	0.0196	CbGeAlD
Celecoxib—MAPK14—epithelium—breast cancer	0.000841	0.0178	CbGeAlD
Celecoxib—MAPK14—skin of body—breast cancer	0.0008	0.0169	CbGeAlD
Celecoxib—ALB—mammary gland—breast cancer	0.000797	0.0169	CbGeAlD
Celecoxib—MAPK14—uterus—breast cancer	0.000695	0.0147	CbGeAlD
Celecoxib—PDPK1—lymph node—breast cancer	0.000684	0.0145	CbGeAlD
Celecoxib—MAPK14—pituitary gland—breast cancer	0.000683	0.0144	CbGeAlD
Celecoxib—MAPK14—adipose tissue—breast cancer	0.00068	0.0144	CbGeAlD
Celecoxib—CA9—female reproductive system—breast cancer	0.000641	0.0136	CbGeAlD
Celecoxib—MAPK14—female reproductive system—breast cancer	0.000625	0.0132	CbGeAlD
Celecoxib—MAPK14—adrenal gland—breast cancer	0.00061	0.0129	CbGeAlD
Celecoxib—CA14—adrenal gland—breast cancer	0.000593	0.0126	CbGeAlD
Celecoxib—MAPK14—bone marrow—breast cancer	0.00059	0.0125	CbGeAlD
Celecoxib—CA4—nipple—breast cancer	0.000587	0.0124	CbGeAlD
Celecoxib—MAPK14—female gonad—breast cancer	0.000569	0.012	CbGeAlD
Celecoxib—CA9—endocrine gland—breast cancer	0.000542	0.0115	CbGeAlD
Celecoxib—MAPK14—endocrine gland—breast cancer	0.000529	0.0112	CbGeAlD
Celecoxib—CYP2C9—mammary gland—breast cancer	0.000498	0.0105	CbGeAlD
Celecoxib—CA2—nipple—breast cancer	0.000487	0.0103	CbGeAlD
Celecoxib—CA12—female reproductive system—breast cancer	0.000474	0.01	CbGeAlD
Celecoxib—CA5B—adipose tissue—breast cancer	0.000463	0.00979	CbGeAlD
Celecoxib—ORM1—endometrium—breast cancer	0.000454	0.00961	CbGeAlD
Celecoxib—Etoricoxib—CYP2D6—breast cancer	0.000441	0.305	CrCbGaD
Celecoxib—CA5B—female reproductive system—breast cancer	0.000425	0.009	CbGeAlD
Celecoxib—CA5B—adrenal gland—breast cancer	0.000415	0.00878	CbGeAlD
Celecoxib—CA2—embryo—breast cancer	0.000402	0.0085	CbGeAlD
Celecoxib—CA12—endocrine gland—breast cancer	0.000401	0.00849	CbGeAlD
Celecoxib—Etoricoxib—CYP3A4—breast cancer	0.000379	0.262	CrCbGaD
Celecoxib—ORM1—female reproductive system—breast cancer	0.000376	0.00796	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—breast cancer	0.000371	0.256	CrCbGaD
Celecoxib—MAPK14—lymph node—breast cancer	0.000366	0.00774	CbGeAlD
Celecoxib—CA5B—endocrine gland—breast cancer	0.00036	0.00762	CbGeAlD
Celecoxib—ABCC4—uterus—breast cancer	0.000355	0.00752	CbGeAlD
Celecoxib—ORM1—bone marrow—breast cancer	0.000355	0.00752	CbGeAlD
Celecoxib—ABCC4—adipose tissue—breast cancer	0.000347	0.00735	CbGeAlD
Celecoxib—CA2—epithelium—breast cancer	0.000328	0.00693	CbGeAlD
Celecoxib—ALB—adrenal gland—breast cancer	0.000322	0.00681	CbGeAlD
Celecoxib—CA4—pituitary gland—breast cancer	0.000321	0.00679	CbGeAlD
Celecoxib—CA4—adipose tissue—breast cancer	0.000319	0.00676	CbGeAlD
Celecoxib—ABCC4—female reproductive system—breast cancer	0.000319	0.00676	CbGeAlD
Celecoxib—ORM1—endocrine gland—breast cancer	0.000318	0.00674	CbGeAlD
Celecoxib—CA2—skin of body—breast cancer	0.000312	0.00659	CbGeAlD
Celecoxib—ABCC4—adrenal gland—breast cancer	0.000312	0.00659	CbGeAlD
Celecoxib—ABCC4—bone marrow—breast cancer	0.000301	0.00638	CbGeAlD
Celecoxib—PTGS2—embryo—breast cancer	0.000296	0.00627	CbGeAlD
Celecoxib—CA4—female reproductive system—breast cancer	0.000294	0.00621	CbGeAlD
Celecoxib—ABCC4—female gonad—breast cancer	0.000291	0.00615	CbGeAlD
Celecoxib—CA4—adrenal gland—breast cancer	0.000286	0.00606	CbGeAlD
Celecoxib—CA4—bone marrow—breast cancer	0.000277	0.00586	CbGeAlD
Celecoxib—ABCC4—endocrine gland—breast cancer	0.00027	0.00572	CbGeAlD
Celecoxib—CA4—female gonad—breast cancer	0.000267	0.00565	CbGeAlD
Celecoxib—CA2—pituitary gland—breast cancer	0.000266	0.00563	CbGeAlD
Celecoxib—CA2—adipose tissue—breast cancer	0.000265	0.0056	CbGeAlD
Celecoxib—Sulfaphenazole—CYP2D6—breast cancer	0.000255	0.176	CrCbGaD
Celecoxib—CA5B—lymph node—breast cancer	0.000249	0.00526	CbGeAlD
Celecoxib—CA4—endocrine gland—breast cancer	0.000248	0.00526	CbGeAlD
Celecoxib—CA2—female reproductive system—breast cancer	0.000243	0.00515	CbGeAlD
Celecoxib—PTGS2—epithelium—breast cancer	0.000242	0.00512	CbGeAlD
Celecoxib—CA2—adrenal gland—breast cancer	0.000238	0.00503	CbGeAlD
Celecoxib—PTGS2—skin of body—breast cancer	0.00023	0.00487	CbGeAlD
Celecoxib—CA2—bone marrow—breast cancer	0.00023	0.00486	CbGeAlD
Celecoxib—CA2—female gonad—breast cancer	0.000221	0.00469	CbGeAlD
Celecoxib—ORM1—lymph node—breast cancer	0.00022	0.00466	CbGeAlD
Celecoxib—PTGS2—endometrium—breast cancer	0.000217	0.00459	CbGeAlD
Celecoxib—CA2—endocrine gland—breast cancer	0.000206	0.00436	CbGeAlD
Celecoxib—CYP2C9—female reproductive system—breast cancer	0.000206	0.00436	CbGeAlD
Celecoxib—PTGS2—uterus—breast cancer	0.0002	0.00423	CbGeAlD
Celecoxib—PTGS2—pituitary gland—breast cancer	0.000196	0.00415	CbGeAlD
Celecoxib—PTGS2—adipose tissue—breast cancer	0.000196	0.00414	CbGeAlD
Celecoxib—ALB—lymph node—breast cancer	0.000193	0.00408	CbGeAlD
Celecoxib—ABCC4—lymph node—breast cancer	0.000187	0.00395	CbGeAlD
Celecoxib—PTGS2—female reproductive system—breast cancer	0.00018	0.0038	CbGeAlD
Celecoxib—PTGS2—adrenal gland—breast cancer	0.000175	0.00371	CbGeAlD
Celecoxib—CYP2C9—endocrine gland—breast cancer	0.000174	0.00369	CbGeAlD
Celecoxib—CA4—lymph node—breast cancer	0.000172	0.00363	CbGeAlD
Celecoxib—PTGS2—bone marrow—breast cancer	0.00017	0.00359	CbGeAlD
Celecoxib—PTGS2—female gonad—breast cancer	0.000164	0.00346	CbGeAlD
Celecoxib—CYP3A4—female reproductive system—breast cancer	0.000157	0.00332	CbGeAlD
Celecoxib—CYP2D6—female reproductive system—breast cancer	0.000155	0.00327	CbGeAlD
Celecoxib—PTGS2—endocrine gland—breast cancer	0.000152	0.00322	CbGeAlD
Celecoxib—CA2—lymph node—breast cancer	0.000142	0.00301	CbGeAlD
Celecoxib—CYP2D6—female gonad—breast cancer	0.000141	0.00298	CbGeAlD
Celecoxib—CYP3A4—endocrine gland—breast cancer	0.000133	0.00281	CbGeAlD
Celecoxib—CYP2D6—endocrine gland—breast cancer	0.000131	0.00277	CbGeAlD
Celecoxib—PTGS2—lymph node—breast cancer	0.000105	0.00222	CbGeAlD
Celecoxib—Eye disorder—Epirubicin—breast cancer	1.92e-05	0.000108	CcSEcCtD
Celecoxib—Tinnitus—Epirubicin—breast cancer	1.92e-05	0.000107	CcSEcCtD
Celecoxib—Haemoglobin—Doxorubicin—breast cancer	1.91e-05	0.000107	CcSEcCtD
Celecoxib—Headache—Gemcitabine—breast cancer	1.91e-05	0.000107	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Capecitabine—breast cancer	1.91e-05	0.000107	CcSEcCtD
Celecoxib—Flushing—Epirubicin—breast cancer	1.91e-05	0.000107	CcSEcCtD
Celecoxib—Cardiac disorder—Epirubicin—breast cancer	1.91e-05	0.000107	CcSEcCtD
Celecoxib—Vomiting—Fluorouracil—breast cancer	1.91e-05	0.000107	CcSEcCtD
Celecoxib—Rhinitis—Doxorubicin—breast cancer	1.91e-05	0.000107	CcSEcCtD
Celecoxib—Dyspepsia—Docetaxel—breast cancer	1.91e-05	0.000107	CcSEcCtD
Celecoxib—Haemorrhage—Doxorubicin—breast cancer	1.9e-05	0.000106	CcSEcCtD
Celecoxib—Hepatitis—Doxorubicin—breast cancer	1.9e-05	0.000106	CcSEcCtD
Celecoxib—Insomnia—Capecitabine—breast cancer	1.9e-05	0.000106	CcSEcCtD
Celecoxib—Hypoaesthesia—Doxorubicin—breast cancer	1.89e-05	0.000106	CcSEcCtD
Celecoxib—Rash—Fluorouracil—breast cancer	1.89e-05	0.000106	CcSEcCtD
Celecoxib—Dermatitis—Fluorouracil—breast cancer	1.89e-05	0.000106	CcSEcCtD
Celecoxib—Pharyngitis—Doxorubicin—breast cancer	1.89e-05	0.000106	CcSEcCtD
Celecoxib—Paraesthesia—Capecitabine—breast cancer	1.88e-05	0.000105	CcSEcCtD
Celecoxib—Decreased appetite—Docetaxel—breast cancer	1.88e-05	0.000105	CcSEcCtD
Celecoxib—Hypersensitivity—Paclitaxel—breast cancer	1.88e-05	0.000105	CcSEcCtD
Celecoxib—Headache—Fluorouracil—breast cancer	1.88e-05	0.000105	CcSEcCtD
Celecoxib—Urinary tract disorder—Doxorubicin—breast cancer	1.88e-05	0.000105	CcSEcCtD
Celecoxib—Oedema peripheral—Doxorubicin—breast cancer	1.87e-05	0.000105	CcSEcCtD
Celecoxib—Dysgeusia—Methotrexate—breast cancer	1.87e-05	0.000105	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Docetaxel—breast cancer	1.87e-05	0.000105	CcSEcCtD
Celecoxib—Connective tissue disorder—Doxorubicin—breast cancer	1.87e-05	0.000105	CcSEcCtD
Celecoxib—Dyspnoea—Capecitabine—breast cancer	1.87e-05	0.000105	CcSEcCtD
Celecoxib—Fatigue—Docetaxel—breast cancer	1.87e-05	0.000104	CcSEcCtD
Celecoxib—Angiopathy—Epirubicin—breast cancer	1.86e-05	0.000104	CcSEcCtD
Celecoxib—Urethral disorder—Doxorubicin—breast cancer	1.86e-05	0.000104	CcSEcCtD
Celecoxib—Nausea—Mitoxantrone—breast cancer	1.86e-05	0.000104	CcSEcCtD
Celecoxib—Nausea—Irinotecan—breast cancer	1.86e-05	0.000104	CcSEcCtD
Celecoxib—Immune system disorder—Epirubicin—breast cancer	1.86e-05	0.000104	CcSEcCtD
Celecoxib—Mediastinal disorder—Epirubicin—breast cancer	1.85e-05	0.000104	CcSEcCtD
Celecoxib—Constipation—Docetaxel—breast cancer	1.85e-05	0.000104	CcSEcCtD
Celecoxib—Back pain—Methotrexate—breast cancer	1.85e-05	0.000104	CcSEcCtD
Celecoxib—Dyspepsia—Capecitabine—breast cancer	1.84e-05	0.000103	CcSEcCtD
Celecoxib—Arrhythmia—Epirubicin—breast cancer	1.84e-05	0.000103	CcSEcCtD
Celecoxib—Asthenia—Paclitaxel—breast cancer	1.83e-05	0.000103	CcSEcCtD
Celecoxib—Decreased appetite—Capecitabine—breast cancer	1.82e-05	0.000102	CcSEcCtD
Celecoxib—Alopecia—Epirubicin—breast cancer	1.82e-05	0.000102	CcSEcCtD
Celecoxib—Nausea—Gemcitabine—breast cancer	1.81e-05	0.000101	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Capecitabine—breast cancer	1.81e-05	0.000101	CcSEcCtD
Celecoxib—Fatigue—Capecitabine—breast cancer	1.81e-05	0.000101	CcSEcCtD
Celecoxib—Pruritus—Paclitaxel—breast cancer	1.81e-05	0.000101	CcSEcCtD
Celecoxib—Vision blurred—Methotrexate—breast cancer	1.8e-05	0.000101	CcSEcCtD
Celecoxib—Mental disorder—Epirubicin—breast cancer	1.8e-05	0.000101	CcSEcCtD
Celecoxib—Erythema multiforme—Doxorubicin—breast cancer	1.8e-05	0.000101	CcSEcCtD
Celecoxib—Constipation—Capecitabine—breast cancer	1.79e-05	0.0001	CcSEcCtD
Celecoxib—Feeling abnormal—Docetaxel—breast cancer	1.78e-05	9.98e-05	CcSEcCtD
Celecoxib—Nausea—Fluorouracil—breast cancer	1.78e-05	9.97e-05	CcSEcCtD
Celecoxib—Eye disorder—Doxorubicin—breast cancer	1.78e-05	9.95e-05	CcSEcCtD
Celecoxib—Tinnitus—Doxorubicin—breast cancer	1.77e-05	9.92e-05	CcSEcCtD
Celecoxib—Gastrointestinal pain—Docetaxel—breast cancer	1.77e-05	9.91e-05	CcSEcCtD
Celecoxib—Anaemia—Methotrexate—breast cancer	1.77e-05	9.89e-05	CcSEcCtD
Celecoxib—Flushing—Doxorubicin—breast cancer	1.76e-05	9.88e-05	CcSEcCtD
Celecoxib—Cardiac disorder—Doxorubicin—breast cancer	1.76e-05	9.88e-05	CcSEcCtD
Celecoxib—Flatulence—Epirubicin—breast cancer	1.76e-05	9.87e-05	CcSEcCtD
Celecoxib—Tension—Epirubicin—breast cancer	1.76e-05	9.83e-05	CcSEcCtD
Celecoxib—Dysgeusia—Epirubicin—breast cancer	1.75e-05	9.81e-05	CcSEcCtD
Celecoxib—Diarrhoea—Paclitaxel—breast cancer	1.75e-05	9.78e-05	CcSEcCtD
Celecoxib—Nervousness—Epirubicin—breast cancer	1.74e-05	9.73e-05	CcSEcCtD
Celecoxib—Back pain—Epirubicin—breast cancer	1.73e-05	9.69e-05	CcSEcCtD
Celecoxib—Feeling abnormal—Capecitabine—breast cancer	1.73e-05	9.67e-05	CcSEcCtD
Celecoxib—Angiopathy—Doxorubicin—breast cancer	1.72e-05	9.66e-05	CcSEcCtD
Celecoxib—Muscle spasms—Epirubicin—breast cancer	1.72e-05	9.63e-05	CcSEcCtD
Celecoxib—Immune system disorder—Doxorubicin—breast cancer	1.72e-05	9.61e-05	CcSEcCtD
Celecoxib—Vertigo—Methotrexate—breast cancer	1.72e-05	9.61e-05	CcSEcCtD
Celecoxib—Gastrointestinal pain—Capecitabine—breast cancer	1.71e-05	9.59e-05	CcSEcCtD
Celecoxib—Mediastinal disorder—Doxorubicin—breast cancer	1.71e-05	9.59e-05	CcSEcCtD
Celecoxib—Abdominal pain—Docetaxel—breast cancer	1.71e-05	9.58e-05	CcSEcCtD
Celecoxib—Body temperature increased—Docetaxel—breast cancer	1.71e-05	9.58e-05	CcSEcCtD
Celecoxib—Leukopenia—Methotrexate—breast cancer	1.71e-05	9.58e-05	CcSEcCtD
Celecoxib—Arrhythmia—Doxorubicin—breast cancer	1.7e-05	9.51e-05	CcSEcCtD
Celecoxib—Dizziness—Paclitaxel—breast cancer	1.69e-05	9.45e-05	CcSEcCtD
Celecoxib—Vision blurred—Epirubicin—breast cancer	1.69e-05	9.44e-05	CcSEcCtD
Celecoxib—Alopecia—Doxorubicin—breast cancer	1.68e-05	9.41e-05	CcSEcCtD
Celecoxib—Cough—Methotrexate—breast cancer	1.67e-05	9.34e-05	CcSEcCtD
Celecoxib—Mental disorder—Doxorubicin—breast cancer	1.67e-05	9.33e-05	CcSEcCtD
Celecoxib—Urticaria—Capecitabine—breast cancer	1.66e-05	9.32e-05	CcSEcCtD
Celecoxib—Body temperature increased—Capecitabine—breast cancer	1.66e-05	9.27e-05	CcSEcCtD
Celecoxib—Abdominal pain—Capecitabine—breast cancer	1.66e-05	9.27e-05	CcSEcCtD
Celecoxib—Anaemia—Epirubicin—breast cancer	1.65e-05	9.26e-05	CcSEcCtD
Celecoxib—Flatulence—Doxorubicin—breast cancer	1.63e-05	9.13e-05	CcSEcCtD
Celecoxib—Chest pain—Methotrexate—breast cancer	1.63e-05	9.11e-05	CcSEcCtD
Celecoxib—Myalgia—Methotrexate—breast cancer	1.63e-05	9.11e-05	CcSEcCtD
Celecoxib—Arthralgia—Methotrexate—breast cancer	1.63e-05	9.11e-05	CcSEcCtD
Celecoxib—Tension—Doxorubicin—breast cancer	1.62e-05	9.09e-05	CcSEcCtD
Celecoxib—Vomiting—Paclitaxel—breast cancer	1.62e-05	9.09e-05	CcSEcCtD
Celecoxib—Dysgeusia—Doxorubicin—breast cancer	1.62e-05	9.07e-05	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.62e-05	9.05e-05	CcSEcCtD
Celecoxib—Rash—Paclitaxel—breast cancer	1.61e-05	9.01e-05	CcSEcCtD
Celecoxib—Dermatitis—Paclitaxel—breast cancer	1.61e-05	9.01e-05	CcSEcCtD
Celecoxib—Nervousness—Doxorubicin—breast cancer	1.61e-05	9e-05	CcSEcCtD
Celecoxib—Vertigo—Epirubicin—breast cancer	1.61e-05	9e-05	CcSEcCtD
Celecoxib—Syncope—Epirubicin—breast cancer	1.6e-05	8.98e-05	CcSEcCtD
Celecoxib—Leukopenia—Epirubicin—breast cancer	1.6e-05	8.96e-05	CcSEcCtD
Celecoxib—Back pain—Doxorubicin—breast cancer	1.6e-05	8.96e-05	CcSEcCtD
Celecoxib—Headache—Paclitaxel—breast cancer	1.6e-05	8.96e-05	CcSEcCtD
Celecoxib—Hypersensitivity—Docetaxel—breast cancer	1.59e-05	8.93e-05	CcSEcCtD
Celecoxib—Muscle spasms—Doxorubicin—breast cancer	1.59e-05	8.91e-05	CcSEcCtD
Celecoxib—Palpitations—Epirubicin—breast cancer	1.58e-05	8.85e-05	CcSEcCtD
Celecoxib—Confusional state—Methotrexate—breast cancer	1.57e-05	8.81e-05	CcSEcCtD
Celecoxib—Loss of consciousness—Epirubicin—breast cancer	1.57e-05	8.8e-05	CcSEcCtD
Celecoxib—Cough—Epirubicin—breast cancer	1.56e-05	8.74e-05	CcSEcCtD
Celecoxib—Anaphylactic shock—Methotrexate—breast cancer	1.56e-05	8.73e-05	CcSEcCtD
Celecoxib—Vision blurred—Doxorubicin—breast cancer	1.56e-05	8.73e-05	CcSEcCtD
Celecoxib—Asthenia—Docetaxel—breast cancer	1.55e-05	8.69e-05	CcSEcCtD
Celecoxib—Infection—Methotrexate—breast cancer	1.55e-05	8.68e-05	CcSEcCtD
Celecoxib—Hypertension—Epirubicin—breast cancer	1.54e-05	8.65e-05	CcSEcCtD
Celecoxib—Hypersensitivity—Capecitabine—breast cancer	1.54e-05	8.64e-05	CcSEcCtD
Celecoxib—Pruritus—Docetaxel—breast cancer	1.53e-05	8.57e-05	CcSEcCtD
Celecoxib—Nervous system disorder—Methotrexate—breast cancer	1.53e-05	8.56e-05	CcSEcCtD
Celecoxib—Anaemia—Doxorubicin—breast cancer	1.53e-05	8.56e-05	CcSEcCtD
Celecoxib—Thrombocytopenia—Methotrexate—breast cancer	1.53e-05	8.55e-05	CcSEcCtD
Celecoxib—Myalgia—Epirubicin—breast cancer	1.52e-05	8.53e-05	CcSEcCtD
Celecoxib—Arthralgia—Epirubicin—breast cancer	1.52e-05	8.53e-05	CcSEcCtD
Celecoxib—Chest pain—Epirubicin—breast cancer	1.52e-05	8.53e-05	CcSEcCtD
Celecoxib—Anxiety—Epirubicin—breast cancer	1.52e-05	8.5e-05	CcSEcCtD
Celecoxib—Nausea—Paclitaxel—breast cancer	1.52e-05	8.49e-05	CcSEcCtD
Celecoxib—Skin disorder—Methotrexate—breast cancer	1.52e-05	8.48e-05	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.51e-05	8.47e-05	CcSEcCtD
Celecoxib—Hyperhidrosis—Methotrexate—breast cancer	1.51e-05	8.44e-05	CcSEcCtD
Celecoxib—Asthenia—Capecitabine—breast cancer	1.5e-05	8.42e-05	CcSEcCtD
Celecoxib—Dry mouth—Epirubicin—breast cancer	1.49e-05	8.34e-05	CcSEcCtD
Celecoxib—Vertigo—Doxorubicin—breast cancer	1.49e-05	8.32e-05	CcSEcCtD
Celecoxib—Anorexia—Methotrexate—breast cancer	1.49e-05	8.32e-05	CcSEcCtD
Celecoxib—Syncope—Doxorubicin—breast cancer	1.48e-05	8.31e-05	CcSEcCtD
Celecoxib—Pruritus—Capecitabine—breast cancer	1.48e-05	8.3e-05	CcSEcCtD
Celecoxib—Leukopenia—Doxorubicin—breast cancer	1.48e-05	8.29e-05	CcSEcCtD
Celecoxib—Diarrhoea—Docetaxel—breast cancer	1.48e-05	8.29e-05	CcSEcCtD
Celecoxib—Confusional state—Epirubicin—breast cancer	1.47e-05	8.24e-05	CcSEcCtD
Celecoxib—Palpitations—Doxorubicin—breast cancer	1.46e-05	8.19e-05	CcSEcCtD
Celecoxib—Oedema—Epirubicin—breast cancer	1.46e-05	8.17e-05	CcSEcCtD
Celecoxib—Anaphylactic shock—Epirubicin—breast cancer	1.46e-05	8.17e-05	CcSEcCtD
Celecoxib—Loss of consciousness—Doxorubicin—breast cancer	1.45e-05	8.14e-05	CcSEcCtD
Celecoxib—Infection—Epirubicin—breast cancer	1.45e-05	8.12e-05	CcSEcCtD
Celecoxib—Cough—Doxorubicin—breast cancer	1.44e-05	8.09e-05	CcSEcCtD
Celecoxib—Shock—Epirubicin—breast cancer	1.44e-05	8.04e-05	CcSEcCtD
Celecoxib—Diarrhoea—Capecitabine—breast cancer	1.43e-05	8.03e-05	CcSEcCtD
Celecoxib—Nervous system disorder—Epirubicin—breast cancer	1.43e-05	8.01e-05	CcSEcCtD
Celecoxib—Dizziness—Docetaxel—breast cancer	1.43e-05	8.01e-05	CcSEcCtD
Celecoxib—Thrombocytopenia—Epirubicin—breast cancer	1.43e-05	8e-05	CcSEcCtD
Celecoxib—Hypertension—Doxorubicin—breast cancer	1.43e-05	8e-05	CcSEcCtD
Celecoxib—Tachycardia—Epirubicin—breast cancer	1.42e-05	7.98e-05	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Methotrexate—breast cancer	1.42e-05	7.96e-05	CcSEcCtD
Celecoxib—Skin disorder—Epirubicin—breast cancer	1.42e-05	7.94e-05	CcSEcCtD
Celecoxib—Hyperhidrosis—Epirubicin—breast cancer	1.41e-05	7.9e-05	CcSEcCtD
Celecoxib—Insomnia—Methotrexate—breast cancer	1.41e-05	7.9e-05	CcSEcCtD
Celecoxib—Myalgia—Doxorubicin—breast cancer	1.41e-05	7.89e-05	CcSEcCtD
Celecoxib—Arthralgia—Doxorubicin—breast cancer	1.41e-05	7.89e-05	CcSEcCtD
Celecoxib—Chest pain—Doxorubicin—breast cancer	1.41e-05	7.89e-05	CcSEcCtD
Celecoxib—Anxiety—Doxorubicin—breast cancer	1.4e-05	7.86e-05	CcSEcCtD
Celecoxib—Paraesthesia—Methotrexate—breast cancer	1.4e-05	7.84e-05	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.4e-05	7.83e-05	CcSEcCtD
Celecoxib—Anorexia—Epirubicin—breast cancer	1.39e-05	7.79e-05	CcSEcCtD
Celecoxib—Dyspnoea—Methotrexate—breast cancer	1.39e-05	7.79e-05	CcSEcCtD
Celecoxib—Somnolence—Methotrexate—breast cancer	1.39e-05	7.76e-05	CcSEcCtD
Celecoxib—Dizziness—Capecitabine—breast cancer	1.39e-05	7.76e-05	CcSEcCtD
Celecoxib—Dry mouth—Doxorubicin—breast cancer	1.38e-05	7.71e-05	CcSEcCtD
Celecoxib—Vomiting—Docetaxel—breast cancer	1.38e-05	7.7e-05	CcSEcCtD
Celecoxib—Dyspepsia—Methotrexate—breast cancer	1.37e-05	7.69e-05	CcSEcCtD
Celecoxib—Rash—Docetaxel—breast cancer	1.36e-05	7.64e-05	CcSEcCtD
Celecoxib—Dermatitis—Docetaxel—breast cancer	1.36e-05	7.63e-05	CcSEcCtD
Celecoxib—Confusional state—Doxorubicin—breast cancer	1.36e-05	7.62e-05	CcSEcCtD
Celecoxib—Decreased appetite—Methotrexate—breast cancer	1.36e-05	7.59e-05	CcSEcCtD
Celecoxib—Headache—Docetaxel—breast cancer	1.36e-05	7.59e-05	CcSEcCtD
Celecoxib—Oedema—Doxorubicin—breast cancer	1.35e-05	7.56e-05	CcSEcCtD
Celecoxib—Anaphylactic shock—Doxorubicin—breast cancer	1.35e-05	7.56e-05	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Methotrexate—breast cancer	1.35e-05	7.54e-05	CcSEcCtD
Celecoxib—Fatigue—Methotrexate—breast cancer	1.34e-05	7.53e-05	CcSEcCtD
Celecoxib—Infection—Doxorubicin—breast cancer	1.34e-05	7.51e-05	CcSEcCtD
Celecoxib—Vomiting—Capecitabine—breast cancer	1.33e-05	7.46e-05	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Epirubicin—breast cancer	1.33e-05	7.45e-05	CcSEcCtD
Celecoxib—Shock—Doxorubicin—breast cancer	1.33e-05	7.44e-05	CcSEcCtD
Celecoxib—Nervous system disorder—Doxorubicin—breast cancer	1.32e-05	7.42e-05	CcSEcCtD
Celecoxib—Thrombocytopenia—Doxorubicin—breast cancer	1.32e-05	7.4e-05	CcSEcCtD
Celecoxib—Rash—Capecitabine—breast cancer	1.32e-05	7.4e-05	CcSEcCtD
Celecoxib—Insomnia—Epirubicin—breast cancer	1.32e-05	7.39e-05	CcSEcCtD
Celecoxib—Dermatitis—Capecitabine—breast cancer	1.32e-05	7.39e-05	CcSEcCtD
Celecoxib—Tachycardia—Doxorubicin—breast cancer	1.32e-05	7.38e-05	CcSEcCtD
Celecoxib—Headache—Capecitabine—breast cancer	1.31e-05	7.35e-05	CcSEcCtD
Celecoxib—Skin disorder—Doxorubicin—breast cancer	1.31e-05	7.35e-05	CcSEcCtD
Celecoxib—Paraesthesia—Epirubicin—breast cancer	1.31e-05	7.34e-05	CcSEcCtD
Celecoxib—Hyperhidrosis—Doxorubicin—breast cancer	1.31e-05	7.31e-05	CcSEcCtD
Celecoxib—Dyspnoea—Epirubicin—breast cancer	1.3e-05	7.29e-05	CcSEcCtD
Celecoxib—Somnolence—Epirubicin—breast cancer	1.3e-05	7.27e-05	CcSEcCtD
Celecoxib—Anorexia—Doxorubicin—breast cancer	1.29e-05	7.21e-05	CcSEcCtD
Celecoxib—Nausea—Docetaxel—breast cancer	1.29e-05	7.2e-05	CcSEcCtD
Celecoxib—Feeling abnormal—Methotrexate—breast cancer	1.29e-05	7.2e-05	CcSEcCtD
Celecoxib—Dyspepsia—Epirubicin—breast cancer	1.28e-05	7.19e-05	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methotrexate—breast cancer	1.28e-05	7.14e-05	CcSEcCtD
Celecoxib—Decreased appetite—Epirubicin—breast cancer	1.27e-05	7.1e-05	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Epirubicin—breast cancer	1.26e-05	7.06e-05	CcSEcCtD
Celecoxib—Fatigue—Epirubicin—breast cancer	1.26e-05	7.05e-05	CcSEcCtD
Celecoxib—Constipation—Epirubicin—breast cancer	1.25e-05	6.99e-05	CcSEcCtD
Celecoxib—Nausea—Capecitabine—breast cancer	1.24e-05	6.97e-05	CcSEcCtD
Celecoxib—Urticaria—Methotrexate—breast cancer	1.24e-05	6.94e-05	CcSEcCtD
Celecoxib—Abdominal pain—Methotrexate—breast cancer	1.23e-05	6.9e-05	CcSEcCtD
Celecoxib—Body temperature increased—Methotrexate—breast cancer	1.23e-05	6.9e-05	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.23e-05	6.89e-05	CcSEcCtD
Celecoxib—Insomnia—Doxorubicin—breast cancer	1.22e-05	6.84e-05	CcSEcCtD
Celecoxib—Paraesthesia—Doxorubicin—breast cancer	1.21e-05	6.79e-05	CcSEcCtD
Celecoxib—Dyspnoea—Doxorubicin—breast cancer	1.2e-05	6.74e-05	CcSEcCtD
Celecoxib—Feeling abnormal—Epirubicin—breast cancer	1.2e-05	6.73e-05	CcSEcCtD
Celecoxib—Somnolence—Doxorubicin—breast cancer	1.2e-05	6.72e-05	CcSEcCtD
Celecoxib—Gastrointestinal pain—Epirubicin—breast cancer	1.19e-05	6.68e-05	CcSEcCtD
Celecoxib—Dyspepsia—Doxorubicin—breast cancer	1.19e-05	6.66e-05	CcSEcCtD
Celecoxib—Decreased appetite—Doxorubicin—breast cancer	1.17e-05	6.57e-05	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Doxorubicin—breast cancer	1.17e-05	6.53e-05	CcSEcCtD
Celecoxib—Fatigue—Doxorubicin—breast cancer	1.16e-05	6.52e-05	CcSEcCtD
Celecoxib—Urticaria—Epirubicin—breast cancer	1.16e-05	6.49e-05	CcSEcCtD
Celecoxib—Constipation—Doxorubicin—breast cancer	1.16e-05	6.47e-05	CcSEcCtD
Celecoxib—Body temperature increased—Epirubicin—breast cancer	1.15e-05	6.46e-05	CcSEcCtD
Celecoxib—Abdominal pain—Epirubicin—breast cancer	1.15e-05	6.46e-05	CcSEcCtD
Celecoxib—Hypersensitivity—Methotrexate—breast cancer	1.15e-05	6.43e-05	CcSEcCtD
Celecoxib—Asthenia—Methotrexate—breast cancer	1.12e-05	6.27e-05	CcSEcCtD
Celecoxib—Feeling abnormal—Doxorubicin—breast cancer	1.11e-05	6.23e-05	CcSEcCtD
Celecoxib—Gastrointestinal pain—Doxorubicin—breast cancer	1.1e-05	6.18e-05	CcSEcCtD
Celecoxib—Pruritus—Methotrexate—breast cancer	1.1e-05	6.18e-05	CcSEcCtD
Celecoxib—Hypersensitivity—Epirubicin—breast cancer	1.08e-05	6.02e-05	CcSEcCtD
Celecoxib—Urticaria—Doxorubicin—breast cancer	1.07e-05	6.01e-05	CcSEcCtD
Celecoxib—Abdominal pain—Doxorubicin—breast cancer	1.07e-05	5.98e-05	CcSEcCtD
Celecoxib—Body temperature increased—Doxorubicin—breast cancer	1.07e-05	5.98e-05	CcSEcCtD
Celecoxib—Diarrhoea—Methotrexate—breast cancer	1.07e-05	5.98e-05	CcSEcCtD
Celecoxib—Asthenia—Epirubicin—breast cancer	1.05e-05	5.86e-05	CcSEcCtD
Celecoxib—Pruritus—Epirubicin—breast cancer	1.03e-05	5.78e-05	CcSEcCtD
Celecoxib—Dizziness—Methotrexate—breast cancer	1.03e-05	5.78e-05	CcSEcCtD
Celecoxib—Diarrhoea—Epirubicin—breast cancer	9.99e-06	5.59e-05	CcSEcCtD
Celecoxib—Hypersensitivity—Doxorubicin—breast cancer	9.95e-06	5.57e-05	CcSEcCtD
Celecoxib—Vomiting—Methotrexate—breast cancer	9.92e-06	5.55e-05	CcSEcCtD
Celecoxib—Rash—Methotrexate—breast cancer	9.83e-06	5.51e-05	CcSEcCtD
Celecoxib—Dermatitis—Methotrexate—breast cancer	9.83e-06	5.5e-05	CcSEcCtD
Celecoxib—Headache—Methotrexate—breast cancer	9.77e-06	5.47e-05	CcSEcCtD
Celecoxib—Asthenia—Doxorubicin—breast cancer	9.69e-06	5.43e-05	CcSEcCtD
Celecoxib—Dizziness—Epirubicin—breast cancer	9.65e-06	5.4e-05	CcSEcCtD
Celecoxib—Pruritus—Doxorubicin—breast cancer	9.56e-06	5.35e-05	CcSEcCtD
Celecoxib—Vomiting—Epirubicin—breast cancer	9.28e-06	5.2e-05	CcSEcCtD
Celecoxib—Nausea—Methotrexate—breast cancer	9.27e-06	5.19e-05	CcSEcCtD
Celecoxib—Diarrhoea—Doxorubicin—breast cancer	9.24e-06	5.17e-05	CcSEcCtD
Celecoxib—Rash—Epirubicin—breast cancer	9.2e-06	5.15e-05	CcSEcCtD
Celecoxib—Dermatitis—Epirubicin—breast cancer	9.2e-06	5.15e-05	CcSEcCtD
Celecoxib—Headache—Epirubicin—breast cancer	9.14e-06	5.12e-05	CcSEcCtD
Celecoxib—Dizziness—Doxorubicin—breast cancer	8.93e-06	5e-05	CcSEcCtD
Celecoxib—Nausea—Epirubicin—breast cancer	8.67e-06	4.85e-05	CcSEcCtD
Celecoxib—Vomiting—Doxorubicin—breast cancer	8.59e-06	4.81e-05	CcSEcCtD
Celecoxib—Rash—Doxorubicin—breast cancer	8.52e-06	4.77e-05	CcSEcCtD
Celecoxib—Dermatitis—Doxorubicin—breast cancer	8.51e-06	4.76e-05	CcSEcCtD
Celecoxib—Headache—Doxorubicin—breast cancer	8.46e-06	4.74e-05	CcSEcCtD
Celecoxib—Nausea—Doxorubicin—breast cancer	8.02e-06	4.49e-05	CcSEcCtD
Celecoxib—CYP2C9—Metabolism—FASN—breast cancer	1.46e-06	1.05e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOTCH1—breast cancer	1.45e-06	1.04e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—BCHE—breast cancer	1.45e-06	1.04e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC5A5—breast cancer	1.45e-06	1.04e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PIK3CA—breast cancer	1.44e-06	1.04e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC5A5—breast cancer	1.43e-06	1.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTA1—breast cancer	1.43e-06	1.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—IDH1—breast cancer	1.43e-06	1.03e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.43e-06	1.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—STAT3—breast cancer	1.43e-06	1.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—breast cancer	1.43e-06	1.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT2—breast cancer	1.43e-06	1.02e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APC—breast cancer	1.42e-06	1.02e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KIT—breast cancer	1.42e-06	1.02e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—breast cancer	1.42e-06	1.02e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—COMT—breast cancer	1.42e-06	1.02e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NAT2—breast cancer	1.42e-06	1.02e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—breast cancer	1.42e-06	1.02e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTP1—breast cancer	1.41e-06	1.01e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGF—breast cancer	1.4e-06	1.01e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PIK3CA—breast cancer	1.4e-06	1.01e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AKT1—breast cancer	1.4e-06	1e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NQO1—breast cancer	1.4e-06	1e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC2A1—breast cancer	1.4e-06	1e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMOX1—breast cancer	1.39e-06	1e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ITPR1—breast cancer	1.39e-06	9.97e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NQO1—breast cancer	1.38e-06	9.95e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC2A1—breast cancer	1.38e-06	9.95e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3CD—breast cancer	1.37e-06	9.84e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK3—breast cancer	1.36e-06	9.79e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP3A4—breast cancer	1.36e-06	9.78e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.36e-06	9.74e-06	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MAPK3—breast cancer	1.36e-06	9.74e-06	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—breast cancer	1.35e-06	9.73e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SERPINE1—breast cancer	1.35e-06	9.73e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP3A4—breast cancer	1.35e-06	9.7e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.34e-06	9.65e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MAPK3—breast cancer	1.34e-06	9.65e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP1B1—breast cancer	1.34e-06	9.62e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—BRAF—breast cancer	1.34e-06	9.59e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCB1—breast cancer	1.34e-06	9.59e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP1B1—breast cancer	1.33e-06	9.54e-06	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MYC—breast cancer	1.32e-06	9.47e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.31e-06	9.43e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TYMS—breast cancer	1.31e-06	9.42e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CAV1—breast cancer	1.31e-06	9.38e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—breast cancer	1.3e-06	9.36e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.3e-06	9.35e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT2—breast cancer	1.3e-06	9.34e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NCOR1—breast cancer	1.3e-06	9.31e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTM1—breast cancer	1.3e-06	9.31e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLA2G4A—breast cancer	1.3e-06	9.31e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—breast cancer	1.3e-06	9.31e-06	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—breast cancer	1.3e-06	9.3e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—breast cancer	1.29e-06	9.29e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NCOA1—breast cancer	1.28e-06	9.18e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NCOA1—breast cancer	1.27e-06	9.1e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—STK11—breast cancer	1.26e-06	9.04e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP19A1—breast cancer	1.26e-06	9.04e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PIK3CD—breast cancer	1.25e-06	8.97e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP19A1—breast cancer	1.25e-06	8.97e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—STK11—breast cancer	1.25e-06	8.97e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.25e-06	8.97e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MED12—breast cancer	1.24e-06	8.93e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DPYD—breast cancer	1.24e-06	8.93e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX1—breast cancer	1.24e-06	8.92e-06	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—breast cancer	1.24e-06	8.91e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SERPINE1—breast cancer	1.24e-06	8.88e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP1A1—breast cancer	1.23e-06	8.83e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MDM2—breast cancer	1.23e-06	8.81e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KRAS—breast cancer	1.22e-06	8.8e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALDOA—breast cancer	1.22e-06	8.79e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RAF1—breast cancer	1.22e-06	8.78e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ERCC2—breast cancer	1.22e-06	8.76e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RELA—breast cancer	1.22e-06	8.74e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ERBB2—breast cancer	1.21e-06	8.69e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—KRAS—breast cancer	1.21e-06	8.67e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MTOR—breast cancer	1.19e-06	8.57e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3CB—breast cancer	1.19e-06	8.57e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CG—breast cancer	1.19e-06	8.55e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NCOA3—breast cancer	1.19e-06	8.53e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—breast cancer	1.18e-06	8.47e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC2A2—breast cancer	1.18e-06	8.47e-06	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AKT1—breast cancer	1.18e-06	8.46e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.17e-06	8.42e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—COMT—breast cancer	1.17e-06	8.41e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTP1—breast cancer	1.17e-06	8.37e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—COMT—breast cancer	1.16e-06	8.34e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CPT1A—breast cancer	1.16e-06	8.3e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTR—breast cancer	1.16e-06	8.3e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCG2—breast cancer	1.16e-06	8.3e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTP1—breast cancer	1.15e-06	8.3e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMOX1—breast cancer	1.15e-06	8.25e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL8—breast cancer	1.15e-06	8.24e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ITPR1—breast cancer	1.15e-06	8.23e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—breast cancer	1.15e-06	8.23e-06	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT1—breast cancer	1.14e-06	8.22e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMOX1—breast cancer	1.14e-06	8.18e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ITPR1—breast cancer	1.14e-06	8.16e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HPGDS—breast cancer	1.13e-06	8.14e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HBA1—breast cancer	1.13e-06	8.09e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PIK3CA—breast cancer	1.13e-06	8.08e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDKN1B—breast cancer	1.12e-06	8.05e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MDM2—breast cancer	1.12e-06	8.04e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RAF1—breast cancer	1.12e-06	8.01e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PIK3CA—breast cancer	1.11e-06	7.97e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ERBB2—breast cancer	1.1e-06	7.93e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCB1—breast cancer	1.1e-06	7.92e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ACHE—breast cancer	1.1e-06	7.89e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTT1—breast cancer	1.1e-06	7.89e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CASP3—breast cancer	1.1e-06	7.89e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—breast cancer	1.1e-06	7.87e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCB1—breast cancer	1.09e-06	7.85e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PIK3CB—breast cancer	1.09e-06	7.82e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTOR—breast cancer	1.09e-06	7.82e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD4—breast cancer	1.09e-06	7.81e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TYMS—breast cancer	1.08e-06	7.78e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TYMS—breast cancer	1.07e-06	7.71e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—breast cancer	1.07e-06	7.71e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTM1—breast cancer	1.07e-06	7.69e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.07e-06	7.69e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NCOR1—breast cancer	1.07e-06	7.69e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCND1—breast cancer	1.07e-06	7.68e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JUN—breast cancer	1.07e-06	7.66e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NCOR1—breast cancer	1.06e-06	7.62e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTM1—breast cancer	1.06e-06	7.62e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.06e-06	7.62e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CTNNB1—breast cancer	1.06e-06	7.6e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAV1—breast cancer	1.06e-06	7.59e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CD—breast cancer	1.05e-06	7.51e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—breast cancer	1.04e-06	7.48e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP17A1—breast cancer	1.04e-06	7.47e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—breast cancer	1.04e-06	7.45e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDKN1A—breast cancer	1.03e-06	7.43e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—breast cancer	1.03e-06	7.42e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTEN—breast cancer	1.03e-06	7.41e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ENO1—breast cancer	1.03e-06	7.4e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS1—breast cancer	1.03e-06	7.4e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—breast cancer	1.03e-06	7.37e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX1—breast cancer	1.03e-06	7.36e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDKN1B—breast cancer	1.02e-06	7.34e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX1—breast cancer	1.02e-06	7.3e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP1A1—breast cancer	1.01e-06	7.29e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.01e-06	7.25e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2D6—breast cancer	1.01e-06	7.25e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK8—breast cancer	1.01e-06	7.25e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ERCC2—breast cancer	1.01e-06	7.23e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP1A1—breast cancer	1.01e-06	7.23e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ERCC2—breast cancer	9.98e-07	7.17e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—breast cancer	9.96e-07	7.16e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NCOA2—breast cancer	9.91e-07	7.12e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—breast cancer	9.88e-07	7.1e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CTNNB1—breast cancer	9.65e-07	6.93e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CG—breast cancer	9.63e-07	6.92e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FASN—breast cancer	9.61e-07	6.91e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—BCHE—breast cancer	9.57e-07	6.88e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SRC—breast cancer	9.56e-07	6.87e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—breast cancer	9.46e-07	6.8e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC5A5—breast cancer	9.46e-07	6.79e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDKN1A—breast cancer	9.43e-07	6.77e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PTEN—breast cancer	9.41e-07	6.76e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—breast cancer	9.38e-07	6.74e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—breast cancer	9.32e-07	6.69e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STAT3—breast cancer	9.22e-07	6.63e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT1—breast cancer	9.19e-07	6.6e-06	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AKT1—breast cancer	9.14e-07	6.57e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NQO1—breast cancer	9.13e-07	6.56e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC2A1—breast cancer	9.13e-07	6.56e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CB—breast cancer	9.12e-07	6.55e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT1—breast cancer	9.06e-07	6.51e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK3—breast cancer	8.81e-07	6.33e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP1B1—breast cancer	8.76e-07	6.29e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAV1—breast cancer	8.73e-07	6.27e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SRC—breast cancer	8.73e-07	6.27e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAV1—breast cancer	8.65e-07	6.21e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HSP90AA1—breast cancer	8.59e-07	6.17e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MYC—breast cancer	8.57e-07	6.16e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—breast cancer	8.55e-07	6.14e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CD—breast cancer	8.46e-07	6.08e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—STAT3—breast cancer	8.41e-07	6.04e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—breast cancer	8.38e-07	6.02e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NCOA1—breast cancer	8.35e-07	6e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.27e-07	5.94e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—STK11—breast cancer	8.23e-07	5.91e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP19A1—breast cancer	8.23e-07	5.91e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAPK3—breast cancer	8.04e-07	5.77e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—breast cancer	7.99e-07	5.74e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CG—breast cancer	7.95e-07	5.71e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KRAS—breast cancer	7.92e-07	5.69e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CG—breast cancer	7.88e-07	5.66e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PTEN—breast cancer	7.88e-07	5.66e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MYC—breast cancer	7.82e-07	5.62e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—breast cancer	7.8e-07	5.6e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—COMT—breast cancer	7.65e-07	5.5e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—breast cancer	7.65e-07	5.49e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTP1—breast cancer	7.62e-07	5.47e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMOX1—breast cancer	7.51e-07	5.4e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ITPR1—breast cancer	7.49e-07	5.38e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CB—breast cancer	7.38e-07	5.3e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—breast cancer	7.31e-07	5.25e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3CA—breast cancer	7.28e-07	5.23e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KRAS—breast cancer	7.22e-07	5.19e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCB1—breast cancer	7.21e-07	5.18e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TYMS—breast cancer	7.08e-07	5.09e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—breast cancer	7.04e-07	5.06e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G4A—breast cancer	7e-07	5.03e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NCOR1—breast cancer	7e-07	5.03e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM1—breast cancer	7e-07	5.03e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CD—breast cancer	6.99e-07	5.02e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CD—breast cancer	6.93e-07	4.98e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—breast cancer	6.9e-07	4.96e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—breast cancer	6.84e-07	4.91e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—breast cancer	6.73e-07	4.84e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX1—breast cancer	6.7e-07	4.81e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PIK3CA—breast cancer	6.64e-07	4.77e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP1A1—breast cancer	6.64e-07	4.77e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—breast cancer	6.6e-07	4.74e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ERCC2—breast cancer	6.58e-07	4.73e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—breast cancer	6.54e-07	4.7e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—breast cancer	6.44e-07	4.63e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTEN—breast cancer	6.37e-07	4.58e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—breast cancer	6.19e-07	4.44e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—breast cancer	6.14e-07	4.41e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CB—breast cancer	6.09e-07	4.38e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CB—breast cancer	6.04e-07	4.34e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—breast cancer	6.04e-07	4.34e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—breast cancer	5.98e-07	4.3e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT1—breast cancer	5.94e-07	4.27e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—breast cancer	5.88e-07	4.22e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAV1—breast cancer	5.71e-07	4.1e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CA—breast cancer	5.56e-07	3.99e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT1—breast cancer	5.42e-07	3.9e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTEN—breast cancer	5.26e-07	3.78e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTEN—breast cancer	5.22e-07	3.75e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CG—breast cancer	5.2e-07	3.73e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CD—breast cancer	4.57e-07	3.28e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKT1—breast cancer	4.54e-07	3.26e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—breast cancer	4.51e-07	3.24e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CA—breast cancer	4.5e-07	3.23e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—breast cancer	4.31e-07	3.1e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CB—breast cancer	3.98e-07	2.86e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—breast cancer	3.95e-07	2.83e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CA—breast cancer	3.71e-07	2.67e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CA—breast cancer	3.68e-07	2.64e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKT1—breast cancer	3.67e-07	2.64e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTEN—breast cancer	3.44e-07	2.47e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKT1—breast cancer	3.03e-07	2.18e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKT1—breast cancer	3.01e-07	2.16e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CA—breast cancer	2.43e-07	1.74e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKT1—breast cancer	1.98e-07	1.42e-06	CbGpPWpGaD
